Australian Clinical Labs Ltd ( (AU:ACL) ) has shared an announcement.
Australian Clinical Labs Ltd has announced an update on its ongoing on-market buy-back program. The company reported that it bought back 146,130 ordinary fully paid securities on the previous day, adding to a total of 3,978,500 securities bought back prior to that. This buy-back initiative is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
More about Australian Clinical Labs Ltd
Australian Clinical Labs Ltd operates in the healthcare industry, providing pathology services across Australia. The company focuses on delivering high-quality diagnostic services to support medical practitioners and patients.
YTD Price Performance: -8.24%
Average Trading Volume: 988,959
Technical Sentiment Signal: Hold
Current Market Cap: A$618.9M
Learn more about ACL stock on TipRanks’ Stock Analysis page.